And Now, Presenting...

Size: px
Start display at page:

Download "And Now, Presenting..."

Transcription

1 Presentation and Handling of Clinical Laboratory Data From Test Tube to Table Randall K. Carlson, Wilmington, DE and Nate Freimark, Lakewood, NJ Omnicare Clinical Research. Inc. INTRODUCTION In human clinical trials of new pharmaceutical agents, clinical laboratory data is a key element of the safety profile for the drug agent being studied. In this paper, background about the categories and types of laboratory parameters commonly collected in clinical trials will be presented. The differences and the various challenges surrounding the use of local vs. central laboratories in analysis and handling of the data will also be discussed. The need for unit conversion and information on the various SAS methods used to accomplish this will be outlined. Finally the paper will provide several examples of typical summary tables commonly used to present clinical laboratory results. These include descriptive statistic, shift tables, CTC grading summaries, as well as examples of the types of graphs that can be produced using SAS/GRAPH. BLOOD COMPONENTS AND COMPOSITION Human Blood is made up of about 45 percent cellular components (primarily Red Blood Cells (RBC), White Blood Cells (WBC), and platelets) and 55 percent fluid (Plasma). The table below lists the major components and their primary biological function COMPONENTS RED BLOOD CELLS WHITE BLOOD CELLS PLATELETS PLASMA FUNCTION CARRY OXYGEN FIGHT INFECTION CLOTTING TRANSPORT NUTRIENTS, HORMONES, PROTEINS CATEGORIES OF COMMON LABORATORY TESTS The most common categories for laboratory tests for human clinical trials are Hematology, Blood (or Serum) Chemistry, Urinalysis and Coagulation. Less common categories are Microbiology, Stool specimens, and testing for specific drugs. While the grouping specific tests sometimes varies from case report form to case report form, in general the Hematology category is of those tests involving the cellular components of the blood, while Blood Chemistry focuses on the plasma components. The Urinalysis group are those tests involving components of the Urine. Coagulation Tests are those that involve blood clotting, these are sometimes grouped into the Hematology test category. Microbiology tests are those testing for the presence of specific bacteria, and fungi. COMMON LABORATORY TESTS The determination of what tests are actually collected during a clinical trial in some degree is determined by the drug being studied and is generally defined in the protocol. Below is a list of commonly collected laboratory tests grouped by category. The groupings are not hard and fast and different studies sometimes group the lab tests in different groups. For example, combining coagulation and hematology into one group, is a common practice. The grouping of lab tests is often used not only for CRF collection, but also to group together the test for presentation in 1

2 the study results. HEMATOLOGY RBC (Red Blood Cell Count) Hemoglobin Hematocrit MCV (Mean Corpuscular Volume) MCH (Mean Corpuscular Hemoglobin) MCHC (Mean Corpuscular Hemoglobin Concentration) WBC (White Blood Cell Counts) Neutrophils (% and/or absolute) Lymphocytes (% and/or absolute) Monocytes (% and/or absolute) Eosinophils (% and/or absolute) Basophils (% and/or absolute) BLOOD CHEMISTRY Albumin LDH (Lactate Dihydrogenase) Alkaline Phosphatase Phosphorus Bicarbonate Potassium BUN (Blood Urea Nitrogen) SGPT (ALT - alanine transaminase) Calcium SGOT (AST- aspartate transaminase) Cholesterol Sodium Creatinine Total Bilirubin Chloride Total Protein Calcium Triglycerides GGT Uric Acid Glucose COAGULATION Prothrombin Time (PT) Partial Thromboplastin Time (PTT) International Normalization Ratio (INR) URINALYSIS Urine ph Urine Specific Gravity 2

3 FUNCTIONAL TESTS Certain Blood chemistry tests are often lumped together because they are indicators for organ and biological functions. They are most often done to make sure that no organ or biological system is being adversely affected by the drug being studied. In some studies these values are reported as a group to add in reviewing the functional data. Some of the common groupings are in the table below System or Organ Liver Kidney Pancreas Electrolytes Nutritional Lipids Lab tests ALT, AST, Alkaline Phosphotase, GGT, LDH, Albumin, Bilirubin BUN, creatinine Amylase Sodium, Potassium, chloride Glucose, fats Triglycerides, Cholesterol(LDL, HDL) CENTRAL VS LOCAL LABS The laboratory data collected for clinical trials is typically handled by two types of labs. Central Labs, such as Covance, CCLS, and Quintiles and local labs which are general on-site in the hospital, or medical unit where the patient visit is taking place. Each type of lab has advantages or problems associated with it. Central labs have the advantage in that each test will be conducted using a standard procedure, which makes for better direct comparison among patients. Data is usually provided electronically. In most cases the central lab will also apply the normal ranges to each patient and lab test, as well as provide the results in the units specified by the sponsor or at least in a common unit based on their own defaults. But of course the samples need to be sent to the central lab which means there is a delay in results to the investigator. Local labs are most often used when an immediate result is needed to allow dosing or entry into the trial. The data is usually captured directly on the case report form. Local labs also complicated by the fact that you have to collect normal ranges from each lab, and sometimes they are not available. The unit of collection is dependent on the lab and will often vary from lab to lab. Standardization of the results to a single unit is often required. UNITS OF MEASUREMENTS The units of measurement for a given lab test often very from lab to lab, in part based on the country the lab is located in. The labs in the US often use what is referred to as Conventional Units, while international labs use SI (Systeme Internationale). SI units are usually preferred for international trials, while US only trials often make use of the conventional units. In some cases the tests are expressed and analysis in both units. PREPERATION FOR ANALYSIS Prior to analysis, it s important that all the values in a given lab test are expressed in terms of a single unit in order to compare apples to apples. It is also important that that lab test be labeled with a single Parameter Name, so that all the apples are included.. There are several ways to program the standardization of the lab parameter, one is to use assignments statements, one for each of the different lab parameter names observed. If labvar = ALBU then lbtest = ALBUMIN ; else if labvar ALBUMIN then lbtest = ALBUMIN ; else if labvar = ALKPH then lbtest = ALkALINE PHOSPHATASE ; else if labvar = ALKPHOS then lbtest = ALKALINE PHOSPHATASE ; 3

4 Another useful method to assign lab names is to create a format and use a put statement. proc format; value $lbtest 'ACANTHOCYTES'='ACANTHOCYTES' 'ALBU','ALBUMIN'='ALBUMIN' 'ALKPH','ALKALINE PHOSPHATASE'='ALKALINE PHOSPHATASE ; lbtest = put(labvar,$lbtest.); Once the lab parameter name is standardized the values for that lab test must all be expressed as a single unit. A number of methods were presented in a paper at NESUG 2006 a. As an example an approach is shown below. First the units are changed and an appropriate conversion factor is assigned. Finally the conversion is applied to the result. select(lbtest); when('basophils, ABS') do; select(labunit); when('k/ul','10^9/l') do; factor=1; lbstresu='10^9/l'; end; otherwise factor=.; end; end; lbstresn=lborresn*factor; TYPICAL LAB SUMMARIES Lab summary tables will vary from study to study depending on what the objectives of that particular clinical trial, Of the more common types are table displaying descriptive statistics such as TABLE 1. They usually describe the lab value and its change or percent change from baseline at various visits or time points. The most common statistics are usually the mean, median, standard deviation, minimum and maximum values. This table would then be repeated for any lab tests collected. When there is a large variation in the results that makes direct comparison difficult, such as cases where local labs are used, shift tables are often used. The lab values are classified as above the normal range, within the normal range, or below the normal range. And then these values are summarized based on the change of categories between baseline and some subsequent time point (usually the last visit in the study). An example of this type of table is shown in Table 2. Another common type of table is to categorize the values into clinically significant categories, such as below a predefined critical value. Then the number of patients who fall into the categories are summarized. Table 3 is an example of this type of table. A very specific version of this type of table is when the Lab values are grouped based on the standard CTC toxicity grading. Table 4 is an example of this. 4

5 GRAPHICAL SUMMARIES Laboratory results are good candidates for graphical summarization. As a graph can give you a quick picture of increases and decrease in lab values over time, as well as a comparison between treatment groups. They are also will reveal data points which are outliers that bear further investigation. There are almost as many examples of graphs as there are studies, as they are often optimized to tell a specific story for a particular study, so it is not possible in the scope of this paper to present them all. One of the more common types of graphs is the box and whisker plot. Figure 1 is an example of this type of plot. In this case it is plotting the value of one lab parameter by visit for a specific treatment group. The line in the middle of the box represents the median value. The box itself are the values representing the 25 th and 75 percentile and the whiskers represent the values within 1.5 of the interquartile ranges. Anything falling outside that range is plotted as a point using the symbol specified in the value option. The BOXT can also have values from BOXT00 to BOXT25. this will change the limits on the top and bottom whiskers. This type of plot allows for comparison of the median values over time, as well as show the variability at a given visit. axis1 label=( angle=90 "&PARAM") ℴ axis2 label=('week OF STUDY') offset=(0.5 in); symbol1 interpol=boxt value=x; proc gplot data=plotds; plot &var*visn / noframe vaxis=axis1 haxis=axis2 Figure 2 is an example of another type of common plot, where two or more treatment groups are compared. In this case the mean of the lab test is being is being plotted for each visit, as well as displaying the values within +/- 1 standard deviation. To accomplish this plot, the mean and standard deviation are first determined at each visit for each treatment group. A data set is created containing the values for mean and then values for the MEAN-SD*1 and MEAN+SD*1 are calculated for each visit and treatment group. proc univariate data=deff_n noprint; by parm trtname visit; var lbstresn; output out=deff_v n=n1 mean=mean1 std=sd1; data deff_v; set deff_v; by parm trtname visit; val=mean1; output; val=mean1+sd1; output; val=mean1-sd1; output; 5

6 This data can then be plotted using the hilo option of the symbol statement. You can vary the options in the symbol statement to change the symbol displayed and the line used to join the mean values for each treatment group, so that they display differently which aids in identifying the data points. The legend statement also controls how the terms are displayed in the legend box. symbol1 l=1 value=diamond width=3 interpol=hiloj line=1; symbol2 l=1 value=square width=3 interpol=hiloj line=5 ; legend1 across=1 cborder=black label=none position=(top inside center) across=2 value=("trta(1-4 MG QID)" "&ztrtb&ztrtbb") mode=share; proc gplot data=ps nocache; plot val*window=trtname / vaxis=axis1 haxis=axis2 legend=legend1; 6

7 Table 1 - Descriptive Statistics Serum Chemistry: ALT (U/L) Analysis Population: All-treated population Pooled (N=679) Observed Change from BL Baseline Mean, SD 56.3, Median 30.0 Min, Max 4, 2852 n 571 End-of-Therapy Mean, SD 54.6, , Median Min, Max 5, , 445 n Post-drug follow-up Mean, SD 41.6, , Median Min, Max 5, , 192 n

8 Table 2 Shift table Laboratory Hematology Test Value Shifts Relative to Normal Reference Range Phase III Studies xxx Intent-to-Treat Population Treatment Group=Placebo (N=128) Final Low Normal High Missing Laboratory Parameter Screening N(%) N(%) N(%) N(%) BASOPHILS (%) Low Normal 0 6( 4.7%) 0 4( 3.1%) High ( 0.8%) Missing 0 4( 3.1%) 1( 0.8%) 112( 87.5%) EOSINOPHILS (%) Low Normal 0 6( 4.7%) 0 5( 3.9%) High Missing 0 5( 3.9%) 0 112( 87.5%) HEMATOCRIT (%) Low 2( 1.6%) 2( 1.6%) 0 0 Normal 4( 3.1%) 101( 78.9%) 0 18( 14.1%) High Missing 0 1( 0.8%) 0 0 HEMOGLOBIN (GM/DL) Low 1( 0.8%) 1( 0.8%) 0 2( 1.6%) Normal 4( 3.1%) 103( 80.5%) 0 16( 12.5%) High Missing 0 1( 0.8%) 0 0 8

9 Table 3 Clinically Significant Phase III Studies xxx Intent-to-Treat Population Number(%) Subjects Placebo Comparator (N=128) (N=127) Lab Parameter (Units) Abnormality Criteria Screening Final Screening Final HEMATOCRIT (%) male: <=37% 2 (1.6%) 1 (0.8%) 0 1 (0.8%) female: <=32% HEMOGLOBIN (GM/DL) male: <=11.5 g/dl 1 (0.8%) 1 (0.8%) 1 (0.8%) 1 (0.8%) female: <=9.5 g/dl LYMPHOCYTES (%) <=10% or >=80% PLATELET COUNT (K/CU MM) <=75,000/mm**3 or >=700,000/mm** WHITE BLOOD CELLS (K/CU MM) <=2800/mm**3 or >=16,000/mm** (0.8%) 0 9

10 Appendix II Table Maximum Toxicity Grade for Hematology by Cycle and Laboratory Test WBC Safety Population Placebo (N=20) Maximum Toxicity Grade # Number of Grade 1 Grade 2 Grade 3 Grade 4 Subjects (Mild) (Moderate) (Severe) (Life-Threatening) Total Number (%) of Subjects with Maximum 20 2( 10.0%) 6( 30.0%) 7( 35.0%) 3( 15.0%) Toxicity Number (%) of Subjects with Maximum Toxicity Grade # PRE-STUDY 20 1( 5.0%) 1( 5.0%) 0 0 CYCLE 1 DAY ( 26.3%) 6( 31.6%) 2( 10.5%) 1( 5.3%) CYCLE 1 DAY ( 31.6%) 1( 5.3%) 5( 26.3%) 2( 10.5%) CYCLE 2 DAY ( 22.2%) 1( 5.6%) 0 CYCLE 2 DAY ( 35.3%) 6( 35.3%) 2( 11.8%) CYCLE 2 DAY ( 29.4%) 4( 23.5%) 2( 11.8%) 0 CYCLE 3 DAY ( 46.7%) CYCLE 3 DAY ( 40.0%) 2( 13.3%) 1( 6.7%) 1( 6.7%) CYCLE 3 DAY ( 30.8%) 0 1( 7.7%) 0 CYCLE 4 DAY 1 3 1( 33.3%) CYCLE 4 DAY 8 3 3(100.0%) CYCLE 4 DAY ( 66.7%) CYCLE 5 DAY 1 3 2( 66.7%) CYCLE 5 DAY 8 3 1( 33.3%) 1( 33.3%) 0 0 CYCLE 5 DAY ( 33.3%) 1( 33.3%) 0 0 CYCLE 6 DAY CYCLE 6 DAY CYCLE 6 DAY

11 11

12 FIGURE 2 - Hi/Lo Plot MEAN FASTING PLASMA GLUCOSE (+/- 1 SD) BY STUDY VISIT LAST OBSERVATION CARRIED FORWARD INTENT-TO-TREAT POPULATION TRT A(1-4 MG QD) TRT B(15-45 MG QD) MEAN FPG (MG/DL) STUDY TIME (WEEKS) 12

13 REFERENCES a Carlson, Randall K. Approaches For Using SAS for Conversion of Pharmaceutical Safety Laboratory Values to Standard Units, 19 th Annual Conference Proceedings of the Northeast SAS Users Group, September ACKNOWLEDGMENTS SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are registered trademarks or trademarks of their respective companies.. Edward Green, Omnicare Clinical Research for the example of the Hi-low graph. CONTACT INFORMATION Randall Carlson, Lead Programmer Omnicare Clinical Research, Inc. 630 Allendale Road King Of Prussia, PA Phone: Fax: Web: Nate Freimark, Lead Programmer Omnicare Clinical Research, Inc. 630 Allendale Road King Of Prussia, PA Phone: Fax: Web: Web: 13

Clinical Laboratory Parameters for Crl:CD(SD) Rats. March, 2006. Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D.

Clinical Laboratory Parameters for Crl:CD(SD) Rats. March, 2006. Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. Clinical Laboratory Parameters for Crl:CD(SD) Rats March, 2006 Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES RIVER LABORATORIES Clinical Laboratory Parameters

More information

Hepatitis C. Laboratory Tests and Hepatitis C

Hepatitis C. Laboratory Tests and Hepatitis C Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what

More information

Case 2:10-md-02179-CJB-SS Document 6427-14 Filed 05/03/12 Page 1 of 5 EXHIBIT 12

Case 2:10-md-02179-CJB-SS Document 6427-14 Filed 05/03/12 Page 1 of 5 EXHIBIT 12 Case 2:10-md-02179-CJB-SS Document 6427-14 Filed 05/03/12 Page 1 of 5 EXHIBIT 12 Case 2:10-md-02179-CJB-SS Document 6427-14 Filed 05/03/12 Page 2 of 5 Components of the PERIODIC MEDICAL CONSULTATION PROGRAM

More information

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code Initial Assessment And Intervention This Code Can Be Used Only Once A Year For First Appointment Medical Nutrition Therapy

More information

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: CLINICAL UNIT: ASSIGNMENT DATES: PATIENT (last initial):

More information

LABORATORY and PATHOLOGY SERVICES

LABORATORY and PATHOLOGY SERVICES LABORATORY and PATHOLOGY SERVICES Policy Neighborhood Health Plan reimburses participating clinical laboratory and pathology providers for tests medically necessary for the diagnosis, treatment and prevention

More information

Albumin. Prothrombin time. Total protein

Albumin. Prothrombin time. Total protein Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis

More information

BIOCHEMISTRY DEPARTMENT

BIOCHEMISTRY DEPARTMENT ALBUMIN 33 46 g/l ALK PHOSPHATASE Up to 11 months Male 133 426 U/L Female 196 553 U/L 11+ months 2 years Male 133 287 U/L Female 196 510 U/L 2+ 8 years Male 133 287 U/L Female 196 426 U/L 8+ 11 years Male

More information

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services Coding and Payment Guide for Laboratory Services An essential coding, billing, and payment resource for laboratory and pathology services Contents Introduction............................... 1 Coding Systems...............................

More information

Implementation Guide

Implementation Guide HAWAII HEALTH INFORMATION CORPORATION HAWAII S SOURCE FOR HEALTHCARE Implementation Guide ASCII HL7 Specifications for Laboratory Observation Reporting Technical Specifications and Transmittal Instructions

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

UNDERSTANDING YOUR LAB TESTS

UNDERSTANDING YOUR LAB TESTS UNDERSTANDING YOUR LAB TESTS CHEMISTRY GLUCOSE Glucose is a simple sugar that serves as the main energy source for the body. Under normal circumstances, insulin transports glucose into the body s cells,

More information

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions. KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term

More information

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl

More information

CTSC Clinical Laboratory. Clinical Laboratory Services CTSC. Clinical & Translational Science Center

CTSC Clinical Laboratory. Clinical Laboratory Services CTSC. Clinical & Translational Science Center Clinical Laboratory The Clinical Laboratory develops and carries out research-related sample analyses to UNM HSC investigators, researchers throughout the United States and world, as well as corporate

More information

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE TEST ITEM DESCRIPTION STANDARD LEVEL Standard level varies among different examination methods. Please check with your medical facility about normal level. MEASURED VALUE Visual Acuity You look at rings

More information

Human Clinical Study for Free Testosterone & Muscle Mass Boosting

Human Clinical Study for Free Testosterone & Muscle Mass Boosting Human Clinical Study for Free Testosterone & Muscle Mass Boosting GE Nutrients, Inc. 920 E. Orangethorpe Avenue, Suite B Anaheim, California 92801, USA Phone: +1-714-870-8723 Fax: +1-732-875-0306 Contact

More information

EXECUTIVE BLOOD WORK PANEL

EXECUTIVE BLOOD WORK PANEL EXECUTIVE BLOOD WORK PANEL Below is a list of all blood and urine testing done on the day of your Executive Medical. MALE Serum Glucose Random Serum Glucose Fasting Creatinine Uric Acid Sodium Potassium

More information

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:. The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal

More information

GENERAL HEALTH SCREEN LAB REPORT. Date of Blood Draw: Time of Blood Draw: Fasting: Yes: X No:

GENERAL HEALTH SCREEN LAB REPORT. Date of Blood Draw: Time of Blood Draw: Fasting: Yes: X No: Dr. Ingrid Pincott Naturopathic Physician 300-1170 Shoppers Row Campbell River, BC V9W 2C8 www.drpincott.com 250-286-3655 or 1-800-898-6699 GENERAL HEALTH SCREEN LAB REPORT Name: Date of Blood Draw: Time

More information

If your doctor has ordered laboratory tests, it s natural

If your doctor has ordered laboratory tests, it s natural A Patient s Guide to Clinical oratory Testing at Kingman Regional Medical Center If your doctor has ordered laboratory tests, it s natural to have questions about why and how the tests are performed. This

More information

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8 Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality

More information

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and Blood Disorders La Crosse, WI UNDERSTANDING MULTIPLE

More information

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Overview of Hematology, http://www.nu.edu.sa/userfiles/mhmorsy/h

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s! How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy

More information

Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results.

Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results. Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results. Copyright 2012 TheLifeInsuranceInsider.com The material Information presented

More information

LIVER FUNCTION TESTS

LIVER FUNCTION TESTS MODULE Liver Function Tests 17 LIVER FUNCTION TESTS 17.1 INTRODUCTION Liver function tests are a group of tests done to assess the functional capacity of the liver as well as any cellular damage to the

More information

The Medical Laboratory Licensing Regulations, 1995

The Medical Laboratory Licensing Regulations, 1995 1 The Medical Laboratory Licensing Regulations, 1995 being Chapter M-9.2 Reg 1 (effective March 1, 1996) as amended by Saskatchewan Regulations 23/2004, 87/2007 and 88/2013. NOTE: This consolidation is

More information

Guide to Common Laboratory Tests for Eating Disorder Patients

Guide to Common Laboratory Tests for Eating Disorder Patients GuidetoCommonLaboratoryTestsforEatingDisorderPatients Test Measure Description Reference Range** CompleteBloodCount Seebelow Levelsofmultiple See (CBC) blood individual components counts WhiteBlood Cell(WBC)

More information

Routine Investigations for Liver Disease a guide

Routine Investigations for Liver Disease a guide fighting childhood liver disease Routine Investigations for Liver Disease a guide Medical Information Series Welcome This leaflet has been written specifically for: Parents/carers of a child with a liver

More information

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605 LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately

More information

Pointe Scientific, Inc. Instrument Application

Pointe Scientific, Inc. Instrument Application Test: ACID PHOS. (NP) Catalog # : A7503 TEST NAME: ACID PHOS. (NP) TEST CODE: [AP (NP)] UNITS: [U/L] PRECISION (DECIMAL): [0] Kinetic MATH MODEL: Fixed Factor FACTOR: 1318.00 [

More information

Hospital stoppages. Scheduled of Charges. Laboratory Investigations

Hospital stoppages. Scheduled of Charges. Laboratory Investigations 52 झ रख ड गजट (अस ध रण) स मव र, 22 सत बर, 2014 अन स च X Hospital stoppages Scheduled of Charges Laboratory Investigations Pathology Sl. No. Investigations Rates (Rs.) 1 Hemogram 90 2 HB% 15 3 ESR 5 4 BTCT

More information

LABORATORY MEDICINE CATEGORY LIST. CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals

LABORATORY MEDICINE CATEGORY LIST. CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals LABORATORY MEDICINE CATEGORY LIST Updated to July 3, 2012 CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals The following tests are restricted to laboratories, vested interest laboratories

More information

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION NUMBER: P 1.01 Page 1 of 1 PATIENT SAFETY SYSTEM/PSS:

More information

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Your health is important to us! The test descriptions listed below are for educational purposes only. Laboratory test interpretation

More information

Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS)

Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book Disease-modifying treatment for multiple sclerosis (MS) Your details Your current therapy: Name: Date of birth: Hospital/clinic: Hospital number: NHS number:

More information

All Acute Care Hospitals and End-Stage Renal Disease Clinics. Subject: Billing and Claim Completion Guidelines for Renal Dialysis Services

All Acute Care Hospitals and End-Stage Renal Disease Clinics. Subject: Billing and Claim Completion Guidelines for Renal Dialysis Services Indiana Health Coverage Programs P R O V I D E R B U L L E T I N BT200223 MAY 29, 2002 To: All Acute Care Hospitals and End-Stage Renal Disease Clinics Subject: Billing and Claim Completion Guidelines

More information

To learn the fundamentals of preparing a clinical trial budget:

To learn the fundamentals of preparing a clinical trial budget: Learning Objectives: To learn the fundamentals of preparing a clinical trial budget: Identifying Potential Members of a Budgeting Team Identifying reasonable / hidden costs in budgeting Understanding the

More information

Bariatric Patients, Nutritional Intervention for

Bariatric Patients, Nutritional Intervention for SKILL COMPETENCY CHECKLIST Bariatric Patients, Nutritional Intervention for Link to Dietitian Practice and Skill Standard Met/Initials Prerequisite Skills Competency Areas Knowledge of how to conduct a

More information

Pointe Scientific, Inc. Instrument Application

Pointe Scientific, Inc. Instrument Application Pointe Scientific, nc. nstrument Application Analyzer: Chemwell Test: Albumin Catalog # : A7502 Options: Assignment Order: 8-way in groups of 4 Optimized order execution Temperature Control to 37C Dispense

More information

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis Blood Objectives Describe the functions of blood Describe blood plasma Explain the functions of red blood cells, white blood cells, and platelets Summarize the process of blood clotting What is Blood?

More information

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Scientific Opinions C2 - Management of scientific committees II; scientific co-operation and networks Revision of the

More information

American Care, Inc. 11255 SW 211 Street Miami, Florida 33189-2240 Member Services: 1.888.777.2555

American Care, Inc. 11255 SW 211 Street Miami, Florida 33189-2240 Member Services: 1.888.777.2555 American Care, Inc. 11255 SW 211 Street Miami, Florida 33189-2240 Member Services: 1.888.777.2555 Discount Medical Plan Organization INDIVIDUAL SERVICE AGREEMENT INTRODUCTION AND WELCOME American Care,

More information

4. is an increased rate of red blood cell destruction. A) Sickle-cell disease B) Hemolytic anemia C) Pernicious anemia Ans: B

4. is an increased rate of red blood cell destruction. A) Sickle-cell disease B) Hemolytic anemia C) Pernicious anemia Ans: B Chapter 11: Blood 1. The hematocrit is composed mainly of A) plasma. B) white blood cells. C) platelets. D) red blood cells. 2. Fifty-five percent of blood is A) liquid. B) plasma. C) formed elements.

More information

TOTAL PROTEIN FIBRINOGEN

TOTAL PROTEIN FIBRINOGEN UNIT: Proteins 16tproteins.wpd Task Determination of Total Protein, Albumin and Globulins Objectives Upon completion of this exercise, the student will be able to: 1. Explain the ratio of albumin and globulin

More information

Laboratory Services Policy

Laboratory Services Policy Policy Number 2014R0014F Annual Approval Date Laboratory Services Policy 1/27/2014 Approved By National Reimbursement Forum United HealthCare Community & State Payment Policy Committee IMPORTANT NOTE ABOUT

More information

DECIPHERING MY MYELOMA LAB RESULTS

DECIPHERING MY MYELOMA LAB RESULTS Myeloma DECIPHERING MY MYELOMA LAB RESULTS Do you understand your myeloma diagnosis and your myeloma lab results? This guide attempts to simplify the complex process of understanding your myeloma markers

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

Clinical Laboratory Parameters For Crl:WI(Han)Rats

Clinical Laboratory Parameters For Crl:WI(Han)Rats Clinical Laboratory Parameters For Crl:WI(Han)Rats INTRODUCTION... 2 PURPOSE... 2 COMMON STUDY PARAMETERS... 2 DATA PRESENTED... 3 NOTES AND ABBREVIATIONS... 3 ACKNOWLEDGMENTS... 4 REFERENCES... 4 REQUEST

More information

DECIPHERING MY MYELOMA LAB RESULTS

DECIPHERING MY MYELOMA LAB RESULTS DECIPHERING MY MYELOMA LAB RESULTS mpatient Myeloma Do you understand your myeloma diagnosis and your myeloma lab results? This guide attempts to simplify the complex process of understanding your myeloma

More information

Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014

Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014 Deutsche Akkreditierungsstelle GmbH German Accreditation Body Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014 Period of validity: 22.04.2015 to 25.09.2018 Date

More information

Blood and Bone Marrow Basics

Blood and Bone Marrow Basics Blood and Bone Marrow Basics Introduction Blood helps distribute the nutrients, oxygen, and hormones the body needs. It also carries toxins and waste materials to the liver and kidneys to be removed from

More information

Exploratory data analysis (Chapter 2) Fall 2011

Exploratory data analysis (Chapter 2) Fall 2011 Exploratory data analysis (Chapter 2) Fall 2011 Data Examples Example 1: Survey Data 1 Data collected from a Stat 371 class in Fall 2005 2 They answered questions about their: gender, major, year in school,

More information

MHDO CompareMaine Updated: 9/17/2015

MHDO CompareMaine Updated: 9/17/2015 Office Visits -- Adult Preventative Care Office Visit (or Wellness Office Visit) 99385 New patient preventive care visit for adult, ages 18 to 39 99386 New patient preventive care visit for adult, ages

More information

3. The Circulatory System

3. The Circulatory System 3. The Circulatory System A. Introduction B. Blood 1. Circulatory system transports water, electrolytes, hormones, enzymes, antibodies, cell, gases and nutrients to all cells and carries away metabolic

More information

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Michael Pine, M.D., M.B.A. Michael Pine and Associates, Inc. mpine@consultmpa.com Overview

More information

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) Protocol Code Tumour Group Contact Physician UGIPNSUNI Gastrointestinal Dr. Hagen

More information

SUGI 29 Posters. Web Server

SUGI 29 Posters. Web Server Paper 151-29 Clinical Trial Online Running SAS. on the Web without SAS/IntrNet. Quan Ren ABSTRACT During clinical trial, it is very important for the project management to have the most recent updated

More information

Methodologies for Converting Microsoft Excel Spreadsheets to SAS datasets

Methodologies for Converting Microsoft Excel Spreadsheets to SAS datasets Methodologies for Converting Microsoft Excel Spreadsheets to SAS datasets Karin LaPann ViroPharma Incorporated ABSTRACT Much functionality has been added to the SAS to Excel procedures in SAS version 9.

More information

SAS CLINICAL TRAINING

SAS CLINICAL TRAINING SAS CLINICAL TRAINING Presented By 3S Business Corporation Inc www.3sbc.com Call us at : 281-823-9222 Mail us at : info@3sbc.com Table of Contents S.No TOPICS 1 Introduction to Clinical Trials 2 Introduction

More information

Effect of Blood Collection Technique in Mice on Clinical Pathology Parameters

Effect of Blood Collection Technique in Mice on Clinical Pathology Parameters HUMAN GENE THERAPY 13:155 162 (January 1, 2002) Mary Ann Liebert, Inc. Effect of Blood Collection Technique in Mice on Clinical Pathology Parameters MICHAEL A. SCHNELL, 1,2 CHRISTINE HARDY, 3 MELANIE HAWLEY,

More information

Urinalysis and Body Fluids CRg. Synovial Fluid. Synovial Fluid. Unit 4. Composition and formation. Functions. Reasons for analysis.

Urinalysis and Body Fluids CRg. Synovial Fluid. Synovial Fluid. Unit 4. Composition and formation. Functions. Reasons for analysis. Urinalysis and Body Fluids CRg Unit 4 Synovial Fluid Synovial Fluid Composition and formation Secreted by cells of synovial membrane Very viscous, clear ultrafiltrate of plasma Contains Hyaluronic acid

More information

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood Thibodeau: Anatomy and Physiology, 5/e Chapter 17: Blood This chapter begins a new unit. In this unit, the first four chapters deal with transportation one of the body's vital functions. It is important

More information

FULL LABORATORY to HOT LABORATORY DR. DAVID OLEESKY

FULL LABORATORY to HOT LABORATORY DR. DAVID OLEESKY FULL LABORATORY to HOT LABORATORY Remodelling the biochemistry service at Macclesfield District General Hospital within a hub and spoke managed network --------------------------------------------------------------------------------------------

More information

Additional Blood Tests

Additional Blood Tests Additional Blood Tests CBC W/Auto Diff The CBC is used as a broad screening test to check for such disorders as anemia, infection, and many other diseases. It is actually panel of tests that examines different

More information

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing Subpart H - Guidelines - General By law, proficiency testing (PT) programs are evaluated initially for CMS

More information

Why is a Comprehensive Metabolic Blood Chemistry panel included in the FNHP?

Why is a Comprehensive Metabolic Blood Chemistry panel included in the FNHP? Why is a Comprehensive Metabolic Blood Chemistry panel included in the FNHP? (A cornerstone of my approach is test, don t guess. Identifying the underlying patterns contributing to poor health is the key

More information

How to Quickly and Easily Understand Your Blood Tests Without A Medical Degree. The Simplified Patient Reference Guide By Ronald J. Grisanti D.C.

How to Quickly and Easily Understand Your Blood Tests Without A Medical Degree. The Simplified Patient Reference Guide By Ronald J. Grisanti D.C. How to Quickly and Easily Understand Your Blood Tests Without A Medical Degree The Simplified Patient Reference Guide By Ronald J. Grisanti D.C. Limits of Liability/Disclaimer of Warranty The author, Ronald

More information

Preparation of Blood Films

Preparation of Blood Films Preparation of Blood Films Principle: Blood film enables us to evaluate WBC, RBC, and PLT morphology, also, allows us to perform differential WBC count, furthermore estimation of WBC and platelets counts

More information

Active centers: 2. Number of patients/subjects: Planned: 20 Randomized: Treated: 20 Evaluated: Efficacy: 13 Safety: 20

Active centers: 2. Number of patients/subjects: Planned: 20 Randomized: Treated: 20 Evaluated: Efficacy: 13 Safety: 20 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov

More information

PharmaSUG 2015 - Paper DV05

PharmaSUG 2015 - Paper DV05 PharmaSUG 2015 - Paper DV05 Techniques of Preparing Datasets for Visualizing Clinical Laboratory Data Amos Shu, MedImmune, Gaithersburg, MD Victor Sun, MedImmune, Gaithersburg, MD ABSTRACT Visualizing

More information

Blood Testing Protocols. Disclaimer

Blood Testing Protocols. Disclaimer Blood Testing Protocols / Page 2 Blood Testing Protocols Here are the specific test protocols recommend by Dr. J.E. Williams. You may request these from your doctor or visit www.readyourbloodtest.com to

More information

Phlebotomy Handbook Blood Collection Essentials Seventh Edition

Phlebotomy Handbook Blood Collection Essentials Seventh Edition Phlebotomy Handbook Blood Collection Essentials Seventh Edition Diana Garza Kathleen Becan-McBride Chapter Four The Cardiovascular System Introduction Circulatory system is a transport system. Contributes

More information

12.1: The Function of Circulation page 478

12.1: The Function of Circulation page 478 12.1: The Function of Circulation page 478 Key Terms: Circulatory system, heart, blood vessel, blood, open circulatory system, closed circulatory system, pulmonary artery, pulmonary vein, aorta, atrioventricular

More information

Graphical Analyses of Clinical Trial Safety Data

Graphical Analyses of Clinical Trial Safety Data Graphical Analyses of Clinical Trial Safety Data Haijun Ma, Kefei Zhou, Amy ia, Matt Austin, George Li, Michael Connell 08/10/07, GBE Scientific Forum verview Current situation of clinical trial safety

More information

COMPREHENSIVE DICTIONARY TO STANDARD BLOOD TESTS

COMPREHENSIVE DICTIONARY TO STANDARD BLOOD TESTS COMPREHENSIVE DICTIONARY TO STANDARD BLOOD TESTS Components of the most commonly ordered complete metabolic profile, any or all of these may be included depending on the doctor s instructions to the laboratory.

More information

ABO-Rh Blood Typing Using Neo/BLOOD

ABO-Rh Blood Typing Using Neo/BLOOD ABO-Rh Blood Typing Using Neo/BLOOD Objectives Determine the ABO and Rh blood type of unknown simulated blood samples. Prepare a simulated blood smear. Examine a prepared blood smear under the microscope

More information

Histogram of Numeric Data Distribution from the UNIVARIATE Procedure

Histogram of Numeric Data Distribution from the UNIVARIATE Procedure Histogram of Numeric Data Distribution from the UNIVARIATE Procedure Chauthi Nguyen, GlaxoSmithKline, King of Prussia, PA ABSTRACT The UNIVARIATE procedure from the Base SAS Software has been widely used

More information

Making Sense of Blood Work in Greyhounds. By William E. Feeman III, DVM, C. Guillermo Couto, DVM, diplomate ACVIM, M. Cristina Iazbik, DVM

Making Sense of Blood Work in Greyhounds. By William E. Feeman III, DVM, C. Guillermo Couto, DVM, diplomate ACVIM, M. Cristina Iazbik, DVM Making Sense of Blood Work in Greyhounds By William E. Feeman III, DVM, C. Guillermo Couto, DVM, diplomate ACVIM, M. Cristina Iazbik, DVM ABSTRACT: The purpose of this article is to provide a brief overview

More information

The child with abnormal liver function tests

The child with abnormal liver function tests The child with abnormal liver function tests Dr Jane Hartley Consultant Paediatric Hepatologist Birmingham Children s Hospital, UK 1 st Global Congress CIP, Paris 2011 Contents Over view of liver anatomy,

More information

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions.

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions. OBJECTIVES: 1. Describe blood according to its tissue type and major functions. 2. Define the term hematology. 3. Name the average volume of blood in a human. 4. Name the two major components of blood

More information

37 2 Blood and the Lymphatic System Slide 1 of 34

37 2 Blood and the Lymphatic System Slide 1 of 34 1 of 34 Blood is a connective tissue that contains both dissolved substances and specialized cells. 2 of 34 The functions of blood include: collecting oxygen from the lungs, nutrients from the digestive

More information

Section. 37Renal Dialysis Facility

Section. 37Renal Dialysis Facility Section 37Renal Dialysis Facility 37 37.1 Enrollment...................................................... 37-2 37.1.1 STAR and STAR+PLUS Program Enrollment.......................... 37-2 37.2 Reimbursement..................................................

More information

Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c

Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c Name: Period: Date: Part A Background The Pancreas and Insulin The following background information has been provided

More information

Phase: IV. Study Period: 20 Jan. 2006-17 Sep. 2008

Phase: IV. Study Period: 20 Jan. 2006-17 Sep. 2008 The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational. Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,

More information

Paper PO12 Pharmaceutical Programming: From CRFs to Tables, Listings and Graphs, a process overview with real world examples ABSTRACT INTRODUCTION

Paper PO12 Pharmaceutical Programming: From CRFs to Tables, Listings and Graphs, a process overview with real world examples ABSTRACT INTRODUCTION Paper PO12 Pharmaceutical Programming: From CRFs to Tables, Listings and Graphs, a process overview with real world examples Mark Penniston, Omnicare Clinical Research, King of Prussia, PA Shia Thomas,

More information

PHYSICIANS LABORATORY SERVICES ANNUAL NOTICE TO PROVIDERS 2012

PHYSICIANS LABORATORY SERVICES ANNUAL NOTICE TO PROVIDERS 2012 , NE 68127-0999 PHYSICIANS LABORATORY SERVICES ANNUAL NOTICE TO PROVIDERS 2012 The Office of Inspector General (OIG) requires all clinical laboratories to send an annual notice to physicians as part of

More information

London Cancer. Mesothelioma Lung Protocols

London Cancer. Mesothelioma Lung Protocols London Cancer Mesothelioma Lung Protocols Version 0.9 Contents 1. Staging... 3 2. Mesothelioma Summary of Chemotherapy Protocols... 4 3. Mesothelioma Chemotherapy Protocols... 7 3.1. Pemetrexed (Alimta

More information

NUTRITION IN LIVER DISEASES

NUTRITION IN LIVER DISEASES NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV

More information

Blood. Functions of Blood. Components of Blood. Transporting. Distributing body heat. A type of connective tissue. Formed elements.

Blood. Functions of Blood. Components of Blood. Transporting. Distributing body heat. A type of connective tissue. Formed elements. Blood Functions of Blood Transporting nutrients respiratory gases waste products Distributing body heat Components of Blood A type of connective tissue Formed elements Living blood cells Plasma Nonliving

More information

NATIONAL CANCER INSTITUTE. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

NATIONAL CANCER INSTITUTE. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma NATIONAL CANCER INSTITUTE Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Basic Trial Information Phase Type Status Age Sponsor Protocol IDs Phase

More information

Intravenous Fluid Selection

Intravenous Fluid Selection BENNMC03_0131186116.qxd 3/9/05 18:24 Page 20 seema Seema-3:Desktop Folder:PQ731: CHAPTER 3 Intravenous Fluid Selection LEARNING OBJECTIVES By the end of this chapter, you should be able to: Describe and

More information

Kaiser Permanente 2016 Sample Fees List 1

Kaiser Permanente 2016 Sample Fees List 1 Kaiser Permanente 2016 Sample Fees List 1 SOUTHERN CALIFORNIA Knowing how much you can expect to pay for care and services can give you peace of mind. This Sample Fees List shows you estimated fees for

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and

More information

NCT00272090. sanofi-aventis HOE901_3507. insulin glargine

NCT00272090. sanofi-aventis HOE901_3507. insulin glargine These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:

More information

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status Patient exhibits two or more of the following SIRS criteria: Temperature greater than 38 o C (100.4 o F) or less SIRS than criteria 36 o C (96.8 o F) Heart Rate greater than 90 beats/minute Respiratory

More information

Department of Pathology and Laboratory Medicine Capital District Health Authority Nova Scotia

Department of Pathology and Laboratory Medicine Capital District Health Authority Nova Scotia Department of Pathology and Laboratory Medicine Capital District Health Authority Nova Scotia Doc #: 10902 Section: \\Management System\PLM\Point of Care Testing\CBC Diff\ Document Owner: ES Team Lead

More information